However, we did not investigate neither CSF PENK-derived peptides, which were also found to be reduced in HD [9, 10] nor the possible effect of dopaminergic therapy on CSF PENK and PDYN values in PD patients. This evidence concerns the gene PDYN and Huntington disease.